AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (4.6 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Review: Biomedical Applications of Carbon Nanotubes

Mohammad Uzair1Muhammad Arshad1( )Salman Shabbir Abbasi1Abida Arshad2Jabar Zaman Khattak1Sobia Tabassum1Umer Bin Zakaria1
Department of Biological Sciences, International Islamic University, Islamabad, Pakistan
Department of Zoology, PMAS-Arid Agriculture University Rawalpindi, Pakistan
Show Author Information

Abstract

Carbon nanotubes are electrically, thermally, and chemically conductive nanoparticles with unique nano-dimensions, unusually strong, and high aspect ratio, which makes them perfect for biomedical applications. Recent researches on carbon nanotubes endow anti-microbial activity against different pathogenic strains of gram-positive (Staphylococcus aureus and S. pyogenes) and gram-negative (Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis), incorporating carbon nanotubes in scaffold for tissue engineering due to their strong characteristics and conducting properties that enhance cell regeneration, and efficacy in drug delivery techniques. Undesirably, the needle-like manifestation of carbon nanotubes and its physical features lead to toxicity problems as respiratory problems, pulmonary toxicity, agglomeration, or cell death. This report aims to describe the possible potentials of carbon nanotubes and their suitability in various aspects of the biomedical field and also highlight their prospects. The antimicrobial activity, applications in tissue engineering, drug delivery, and the toxicology of carbon nanotubes are also discussed here.

References

[1]

S. Iijima, Helical microtubules of graphitic carbon. Nature, 1991, 354(6348): 56-58.

[2]

N. Saifuddin, A. Raziah, and A.R. Junizah, Carbon nanotubes: a review on structure and their interaction with proteins. Journal of Chemistry, 2013: Article ID 676815.

[3]
S. Bosi, L. Ballerini, and M. Prato. Carbon nanotubes in tissue engineering. Making and exploiting fullerenes, graphene, and carbon nanotubes. Springer; 2013: 181-204.
[4]

K.S. Ibrahim, Carbon nanotubes-properties and applications: a review. AZO Nano, 2013, 14(3): 131-144.

[5]

W. Yang, P. Thordarson, J.J. Gooding, et al., Carbon nanotubes for biological and biomedical applications. Nanotechnology, 2007, 18(41): 412001.

[6]

E.T. Thostenson, Z. Ren, T-WJCs Chou, technology. Advances in the science and technology of carbon nanotubes and their composites: a review. Composites science and technology 2001; 61(13): 1899-1912.

[7]

S Vardharajula, S.Z. Ali, P.M. Tiwari, et al. Functionalized carbon nanotubes: biomedical applications. International Journal of Nanomedicine, 2012, 7: 5361.

[8]

T. Kuo, C. Chi, and I.N. Lin. Synthesis of carbon nanotubes by laser ablation of graphites at room temperature. Japanese Journal of Applied Physics, 2001, 40(12R): 7147.

[9]

T. Ebbesen, P. Ajayan. Large-scale synthesis of carbon nanotubes. Nature, 1992, 358(6383): 220-222.

[10]

V.K. Varadan, J. Xie, Large-scale synthesis of multi-walled carbon nanotubes by microwave CVD. Smart Materials and Structures, 2002, 11(4): 610.

[11]

J.V. Veetil, K. Ye, Tailored carbon nanotubes for tissue engineering applications. Biotechnology Progress, 2009, 25(3): 709-721.

[12]

C. Aloysius, A.A. Varghese, S.P. Ali, et al., Antibacterial activity of carbon nanoparticles isolated from chimney soot. IET Nanobiotechnology, 2018, 13(3): 316-319.

[13]

S. Varghese, S. Kuriakose, and S.J. Jose, Antimicrobial activity of carbon nanoparticles isolated from natural sources against pathogenic Gram-negative and Gram-positive bacteria. Journal of Nanoscience, 2013, 2013.

[14]

O.A. Dyatlova, J. Gomis-Bresco, E. Malic, et al., Dielectric screening effects on transition energies in aligned carbon nanotubes. Physical Review B, 2012, 85(24): 245449.

[15]

C.D. Hernandez, M. Zhang, S. Fang, et al., Multifunctional characteristics of carbon nanotube (CNT) yarn composites. Multifunctional Nanocomposites and Nanomaterials International Conference, 2006.

[16]

H. HE, L.A. Pham-Huy, P. Dramou, et al., Carbon nanotubes: applications in pharmacy and medicine. BioMed Research International, 2013, 2013.

[17]

S.K. Smart, A.L. Cassady, G.Q. Lu, et al., The biocompatibility of carbon nanotubes. Carbon, 2006, 44(6): 1034-1047.

[18]

A.M. Popov, Y.E. Lozovik, S. Fiorito, et al., Biocompatibility and applications of carbon nanotubes in medical nanorobots. International Journal of Nanomedicine, 2007, 2(3): 361.

[19]

P.A. Tran, L. Zhang, and T. Webster, Carbon nanofibers and carbon nanotubes in regenerative medicine. Advanced Drug Delivery Reviews, 2009, 61(12): 1097-114.

[20]

J. Simon, E. Flahaut, and M. Golzio, Overview of carbon nanotubes for biomedical applications. Materials 2019, 12(4): 624.

[21]

S.Y. Madani, N. Naderi, O. Dissanayake, et al., A new era of cancer treatment: Carbon nanotubes as drug delivery tools. International Journal of Nanomedicine, 2011, 6: 2963.

[22]

S. Kang, M. Pinault, L.D. Pfefferle, et al., Single-walled carbon nanotubes exhibit strong antimicrobial activity. Langmuir, 2007, 23(17): 8670-8673.

[23]

E Bekyarova, Y. Ni, E.B. Malarkey, et al., Applications of carbon nanotubes in biotechnology and biomedicine. Journal of Biomedical Nanotechnology, 2005, 1(1): 3-17.

[24]

C.L. Ventola, The antibiotic resistance crisis: Part 1: Causes and threats. Pharmacy and Therapeutics, 2015, 40(4): 277.

[25]

S.M. Dizaj, A. Mennati, S. Jafari, et al., Antimicrobial activity of carbon-based nanoparticles. Advanced Pharmaceutical Bulletin, 2015, 5(1): 19.

[26]

C. Yang, J. Mamouni, Y. Tang, et al., Antimicrobial activity of single-walled carbon nanotubes: Length effect. Langmuir, 2010, 26(20): 16013-16019.

[27]

H. Chen, B. Wang, D. Gao, et al., Broad-spectrum antibacterial activity of carbon nanotubes to human gut bacteria. Small, 2013, 9(16): 2735-2746.

[28]

S.S.N. Fernando, T. Gunasekara, and J. Holton, Antimicrobial nanoparticles: Applications and mechanisms of action. Sri Lankan Journal of Infectious Diseases, 2018, 8(1): 2-11.

[29]

A.A. Shvedova, A. Pietroiusti, B. Fadeel, et al., Mechanisms of carbon nanotube-induced toxicity: Focus on oxidative stress. Toxicology and Applied Pharmacology, 2012, 261(2): 121-133.

[30]

M. Lamberti, P. Pedata, N. Sannolo, et al., Carbon nanotubes: Properties, biomedical applications, advantages and risks in patients and occupationally-exposed workers. International Journal of Immunopathology and Pharmacology, 2015.

[31]

X. Chen, H.J. Schluesener, Nanosilver: A nanoproduct in medical application. Toxicology Letters, 2008, 176(1): 1-12.

[32]

Y. Seo, J. Hwang, J. Kim, et al., Antibacterial activity and cytotoxicity of multi-walled carbon nanotubes decorated with silver nanoparticles. International Journal of Nanomedicine, 2014, 9: 4621.

[33]

L.R. Arias, L. Yang, Inactivation of bacterial pathogens by carbon nanotubes in suspensions. Langmuir, 2009, 25(5): 3003-3012.

[34]

D. Howard, L.D. Buttery, K.M. Shakesheff, et al., Tissue engineering: strategies, stem cells and scaffolds. Journal of Anatomy, 2008, 213(1): 66-72.

[35]

S Pina, V.P. Ribeiro, C.F. Marques, et al., Scaffolding strategies for tissue engineering and regenerative medicine applications. Materials, 2019, 12(11): 1824.

[36]

N.C. Rivron, J.J. Liu, J. Rouwkema, et al., Engineering vascularised tissues in vitro. Eur Cell Mater, 2008, 15(2).

[37]

S.L. Edwards, J.A. Werkmeister, and J. Ramshaw, Carbon nanotubes in scaffolds for tissue engineering. Expert Review of Medical Devices, 2009, 6(5): 499-505.

[38]

A. Abarrategi, M.C. Gutierrez, C. Moreno-Vicente, et al., Multiwall carbon nanotube scaffolds for tissue engineering purposes. Biomaterials, 2008, 29(1): 94-102.

[39]

K. Aoki, N. Saito, Biocompatibility and Carcinogenicity of Carbon Nanotubes as Biomaterials. Nanomaterials, 2020, 10(2): 264.

[40]

A. Magrez, S. Kasas, V. Salicio, et al., Cellular toxicity of carbon-based nanomaterials. Nano letters 2006, 6(6): 1121-1125.

[41]

J. Silver, M.E. Schwab, and P.G. Popovich, Central nervous system regenerative failure: role of oligodendrocytes, astrocytes, and microglia. Cold Spring Harbor Perspectives in Biology, 2015, 7(3): a020602.

[42]

D.J. Guggenmos, M. Azin, S. Barbay, et al., Restoration of function after brain damage using a neural prosthesis. Proceedings of the National Academy of Sciences, 2013, 110(52): 21177-21182.

[43]

C.R. Carvalho, J. Silva-Correia, J.M. Oliveira, et al., Nanotechnology in peripheral nerve repair and reconstruction. Adv Drug Deliv, 2019, 148: 308-343.

[44]

S. Bosi, A. Fabbro, L. Ballerini, et al., Carbon nanotubes: A promise for nerve tissue engineering? Nanotechnology Reviews, 2013, 2(1): 47-57.

[45]

A. Fabbro, S. Bosi, L. Ballerini, et al., Carbon nanotubes: artificial nanomaterials to engineer single neurons and neuronal networks. ACS Chemical Neuroscience, 2012, 3(8): 611-618.

[46]

S. Giannona, I. Firkowska, J. Rojas-Chapana, et al., Vertically aligned carbon nanotubes as cytocompatible material for enhanced adhesion and proliferation of osteoblast-like cells. Journal of Nanoscience and Nanotechnology, 2007, 7(4-5): 1679-1683.

[47]

M.P. Mattson, R.C. Haddon, and A.M. Rao, Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth. Journal of Molecular Neuroscience, 2000, 14(3): 175-182.

[48]

H. Hu, Y. Ni, V. Montana, et al., Chemically functionalized carbon nanotubes as substrates for neuronal growth. Nano Letters, 2004, 4(3): 507-511.

[49]

C. Salvador-Morales, E. Flahaut, E. Sim, et al., Complement activation and protein adsorption by carbon nanotubes. Molecular Immunology, 2006, 43(3): 193-201.

[50]

Y. Ni, H. Hu, E.B. Malarkey, et al., Chemically functionalized water soluble single-walled carbon nanotubes modulate neurite outgrowth. Journal of Nanoscience and Nanotechnology, 2005, 5(10): 1707-1712.

[51]

P. Chocholata, V. Kulda, and V. Babuska, Fabrication of scaffolds for bone-tissue regeneration. Materials, 2019, 12(4): 568.

[52]

S. Mann, S. Weiner, Biomineralization: Structural questions at all length scales. Journal of Structural Biology, 1999, 3(126): 179-181.

[53]

E.H. Burger, J. Klein-Nulend, Mechanotransduction in bone - role of the lacunocanalicular network. The FASEB Journal, 1999, 13(9001): S101-S112.

[54]

B. Pei, W. Wang, N. Dunne, et al., Applications of carbon nanotubes in bone tissue regeneration and engineering: Superiority, concerns, current advancements, and prospects. Nanomaterials, 2019, 9(10): 1501.

[55]

K. Sahithi, M. Swetha, K. Ramasamy, et al., Polymeric composites containing carbon nanotubes for bone tissue engineering. International Journal of Biological Macromolecules, 2010, 46(3): 281-283.

[56]

K.P.A. Saffar, N. JamilPour, and G. Rouhi, Carbon nanotubes in bone tissue engineering. Biomedical Engineering, 2009: 477-498.

[57]

M. Arora, E.K.S. Chan, S. Gupta, et al., Polymethylmethacrylate bone cements and additives: A review of the literature. World Journal of Orthopedics, 2013, 4(2): 67.

[58]

B. Marrs, R. Andrews, T. Rantell, et al., Augmentation of acrylic bone cement with multiwall carbon nanotubes. Journal of Biomedical Materials Research Part A, 2006, 77(2): 269-276.

[59]

N. Aoki, T. Akasaka, F. Watari, et al., Carbon nanotubes as scaffolds for cell culture and effect on cellular functions. Dental Materials Journal, 2007, 26(2): 178-185.

[60]

E. Hirata, M. Uo, H. Takita, et al., Development of a 3D collagen scaffold coated with multiwalled carbon nanotubes. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2009, 90(2): 629-634.

[61]

A.A. White, S.M. Best, and I.A. Kinloch, Hydroxyapatitecarbon nanotube composites for biomedical applications: a review. International Journal of Applied Ceramic Technology, 2007, 4(1): 1-13.

[62]

R. Eivazzadeh-Keihan, A. Maleki, M. De La Guardia, et al., Carbon based nanomaterials for tissue engineering of bone: Building new bone on small black scaffolds: A review. Journal of Advanced Research, 2019, 18: 185-201.

[63]

K. Das, A. Madhusoodan, B. Mili, et al., Functionalized carbon nanotubes as suitable scaffold materials for proliferation and differentiation of canine mesenchymal stem cells. International Journal of Nanomedicine, 2017, 12: 3235.

[64]

B. Zhao, H. Hu, S.K. Mandal, et al., A bone mimic based on the self-assembly of hydroxyapatite on chemically functionalized single-walled carbon nanotubes. Chemistry of Materials, 2005, 17(12): 3235-3241.

[65]
T. Gaziano, K.S. Reddy, F. Paccaud, et al., Cardiovascular disease. Disease Control Priorities in Developing Countries. 2nd edition. The International Bank for Reconstruction and Development / The World Bank; Oxford University Press, 2006.
[66]

X. Geng, B. Liu, J. Liu, et al., Interfacial tissue engineering of heart regenerative medicine based on soft cell-porous scaffolds. Journal of Thoracic Disease, 2018, 10(Suppl 20): S2333.

[67]

K. Ashtari, H. Nazari, H. Ko, et al., Electrically conductive nanomaterials for cardiac tissue engineering. Advanced Drug Delivery Reviews, 2019, 144: 162-179.

[68]

A.M. Martins, G. Eng, S.G. Caridade, et al., Electrically conductive chitosan/carbon scaffolds for cardiac tissue engineering. Biomacromolecules, 2014, 15(2): 635-643.

[69]

B. Gorain, H. Choudhury, M. Pandey, et al., Carbon nanotube scaffolds as emerging nanoplatform for myocardial tissue regeneration: a review of recent developments and therapeutic implications. Biomedicine & Pharmacotherapy, 2018, 104: 496-508.

[70]

S.R. Shin, S.M. Jung, M. Zalabany, et al., Carbon-nanotube-embedded hydrogel sheets for engineering cardiac constructs and bioactuators. ACS Nano, 2013, 7(3): 2369-2380.

[71]

W. Zhang, Z. Zhang, and Y. Zhang, The application of carbon nanotubes in target drug delivery systems for cancer therapies. Nanoscale Research Letters, 2011, 6(1): 555.

[72]

A. Bianco, K. Kostarelos, and M. Prato, Applications of carbon nanotubes in drug delivery. Current Opinion in Chemical Biology, 2005, 9(6): 674-679.

[73]

T. Saliev, The advances in biomedical applications of carbon nanotubes. C—Journal of Carbon Research, 2019, 5(2): 29.

[74]

M. Karimi, N. Solati, A. Ghasemi, et al., Carbon nanotubes part Ⅱ: A remarkable carrier for drug and gene delivery. Expert Opinion on Drug Delivery, 2015, 12(7): 1089-1105.

[75]

B. Kang, S. Chang, Y. Dai, et al., Cell response to carbon nanotubes: Size‐dependent intracellular uptake mechanism and subcellular fate. Small, 2010, 6(21): 2362-2366.

[76]

S.K.S. Kushwaha, S. Ghoshal, A.K. Rai, et al., Carbon nanotubes as a novel drug delivery system for anticancer therapy: A review. Brazilian Journal of Pharmaceutical Sciences, 2013, 49(4): 629-643.

[77]

K.O. Alfarouk, C.M. Stock, S. Taylor, et al., Resistance to cancer chemotherapy: Failure in drug response from ADME to P-gp. Cancer Cell International, 2015, 15(1): 71.

[78]

X. Wang, H. Zhang, and X. Chen, Drug resistance and combating drug resistance in cancer. Cancer Drug Resistance, 2019, 2: 141-160.

[79]

A. Sanginario, B. Miccoli, and D. Demarchi, Carbon nanotubes as an effective opportunity for cancer diagnosis and treatment. Biosensors, 2017, 7(1): 9.

[80]

M. Lamberti, S. Zappavigna, N. Sannolo, et al., Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers. Expert Opinion on Drug Delivery, 2014, 11(7): 1087-1101.

[81]

Z. Liu, K. Chen, C. Davis, et al., Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Research, 2008, 68(16): 6652-6660.

[82]

S. Yu, Q. Li, J. Wang, et al., A targeted drug delivery system based on carbon nanotubes loaded with lobaplatin toward liver cancer cells. Journal of Materials Research, 2018, 33(17): 2565-2575.

[83]

S. Yu, Y. Zhang, L. Chen, et al., Antitumor effects of carbon nanotube-drug complex against human breast cancer cells. Experimental and Therapeutic Medicine, 2018, 16(2): 1103-1110.

[84]

J. Dillon, L. Mulvanny, Carbon nanotubes-MGMRTM - a medical-grade carbon nanotube designed for medical applications. Drug Delivery, 2016, 16(5).

[85]
Biopharma dealmakers. MGMR, a next-generation carbon nanotube, solves drug development challenges 2016. Retrieved from <https://biopharmadealmakers.nature.com/documents/12891-biopact-profile-november-2016>.
[86]
Drug development & delivery. Carbon nanotubes - MGMRTM - A medical-grade carbon nanotube designed for medical applications 2016. Retrieved from <https://drug-dev.com/carbon-nanotubes-mgmr-a-medical-grade-carbon-nanotube-designed-for-medical-applications/>.
[87]

C.A. Poland, R. Duffin, I. Kinloch, et al., Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nature Nanotechnology, 2008, 3(7): 423.

[88]

M.C.F. Jaurand, A. Renier, and J. Daubriac, Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk? Particle and Fibre Toxicology, 2009, 6(1): 16.

[89]

T. Chernova, F.A. Murphy, S. Galavotti, et al., Long-fiber carbon nanotubes replicate asbestos-induced mesothelioma with disruption of the tumor suppressor gene Cdkn2a (Ink4a/Arf). Current Biology, 2017, 27(21): 3302-3314.

[90]

A. Helland, P. Wick, A. Koehler, et al., Reviewing the environmental and human health knowledge base of carbon nanotubes. Environmental Health Perspectives, 2007, 115(8): 1125-1131.

[91]

D. Mohanta, S. Patnaik, S. Sood, et al., Carbon nanotubes: Evaluation of toxicity at biointerfaces. Journal of Pharmaceutical Analysis, 2019, 9(5): 293-300.

[92]

J. Kolosnjaj-Tabi, J. Just, K.B. Hartman, et al., Anthropogenic carbon nanotubes found in the airways of Parisian children. EBioMedicine, 2015, 2(11): 1697-1704.

[93]

Y. Rodriguez-Yanez, B. Munoz, and A. Albores, Mechanisms of toxicity by carbon nanotubes. Toxicology Mechanisms and Methods, 2013, 23(3): 178-195.

[94]

J. Kolosnjaj, H. Szwarc, and F. Moussa, Toxicity studies of carbon nanotubes. Bio-Applications of Nanoparticles, 2007: 181-204.

[95]

S.Y. Madani, A. Mandel, and A.M. Seifalian, A concise review of carbon nanotube's toxicology. Nano Reviews, 2013, 4(1): 21521.

[96]

H. Dumortier, S. Lacotte, G. Pastorin, et al., Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells. Nano Letters, 2006, 6(7): 1522-1528.

[97]

C.M. Sayes, F. Liang, J.L. Hudson, et al., Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicology Letters, 2006, 161(2): 135-142.

Nano Biomedicine and Engineering
Pages 82-93
Cite this article:
Uzair M, Arshad M, Abbasi SS, et al. Review: Biomedical Applications of Carbon Nanotubes. Nano Biomedicine and Engineering, 2021, 13(1): 82-93. https://doi.org/10.5101/nbe.v13i1.p82-93

580

Views

70

Downloads

2

Crossref

2

Scopus

Altmetrics

Received: 27 July 2020
Accepted: 27 October 2020
Published: 22 February 2021
© Mohammad Uzair, Muhammad Arshad, Salman Shabbir Abbasi, Abida Arshad, Jabar Zaman Khattak, Sobia Tabassum, and Umer Bin Zakaria.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Return